10.06.2011 • NewsDIDPGlaxoSmithKline (GSK)GSK

Hong Kong Orders GSK To Recall Antibiotic Due to Plasticizer

Hong Kong has ordered GlaxoSmithKline(GSK) to recall an pediatric antibiotic manufactured in France over the presence of a plasticizer in the product, raising safety and quality concerns.       

The Department of Health said in a statement that diisodecyl phthalate (DIDP) was detected in GSK's Augmentin powder for syrup 156mg/5ml, a product for children.  A government laboratory test detected the presence of DIDP was two times higher than Europe's specific migration limit for food contact materials.

DIDP's safety for human consumption was not well established, but data from animal studies suggested long-term consumption of high levels of DIDP may affect the liver, the government said.      

The government said it had stepped up surveillance of pharmaceutical products containing flavoring agents after  Chinese media reports that Chinese importers had recalled bottled beverages from Taiwan that were suspected of being contaminated with a cancer-causing plastic additive.

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read